Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.57 |
| ▸ | NPY4R | P50391 | 9/20 | 0.54 |
| ▸ | NPY1R | P25929 | 6/20 | 0.54 |
| ▸ | NPY2R | P49146 | 4/20 | 0.54 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.54 |
| ▸ | VIPR2 | P41587 | 6/20 | 0.53 |
| ▸ | VIPR1 | P32241 | 4/20 | 0.53 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30773467 | 0.94 | NPY4R (0.55) | TFPINPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30918767 | 0.93 | NPY4R (0.57) | TFPINPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29611536 | 0.92 | NPY4R (0.58) | TFPINPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL10940573 | 0.92 | NPY4R (0.62) | TFPINPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30493020 | 0.91 | TFPI (0.51) | TFPINPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29611523 | 0.90 | NPY4R (0.60) | TFPINPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29512422 | 0.89 | NPY4R (0.61) | TFPINPY4RNPY1RNPY2RNPY5R | |
| Acetic Acid SCHEMBL11119195 | 0.89 | NPY4R (0.67) | TFPINPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL8815384 | 0.89 | NPY4R (0.62) | TFPINPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL8813021 | 0.89 | NPY4R (0.62) | TFPINPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230103704-A1 | HUMAN ANTI-INFLAMMATORY PEPTIDES FOR THE INHALATORY TREATMENT OF INFLAMMATORY PULMONARY ISSUES | ADVITA LIFESCIENCE GMBH (DE) | 2023-04-06 | — | — | US | disclosed |